Company Filing History:
Years Active: 2022
Title: The Innovations of Yongil Jin: Pioneering Advances in Immuno-Oncology
Introduction
Yongil Jin, a dedicated inventor based in Emeryville, California, has made significant contributions to the field of immuno-oncology. With a focused portfolio that includes one granted patent, his work embodies the spirit of innovation in the realm of cancer treatment.
Latest Patents
Yongil Jin holds a notable patent titled "Compounds and methods for EP300 or CBP modulation and indications therefor". This patent features compounds of Formula I and explores novel approaches to modulate important pathways in cancer biology, potentially leading to groundbreaking therapeutic applications.
Career Highlights
At Opna Immuno-Oncology SA, Yongil Jin has played a vital role in advancing research that targets specific pathways involved in cancer progression. His innovative mindset and research endeavors have propelled the company towards achieving its mission of developing effective immuno-oncology treatments.
Collaborations
Throughout his career, Yongil has collaborated with esteemed colleagues such as Wayne Spevak and John Buell. These partnerships highlight his commitment to teamwork and the pooling of expertise, which is crucial in the rapidly evolving field of cancer research.
Conclusion
Yongil Jin's innovative contributions, particularly in the realm of EP300 and CBP modulation, underscore the importance of ongoing research in immuno-oncology. His work not only exemplifies the dedication of inventors in the medical field but also paves the way for potential advancements that can improve patient outcomes in cancer therapy.